Diazoxide-associated pulmonary hypertension in a patient with noncompaction cardiomyopathy

Development of pulmonary hypertension after initiation of diazoxide for the treatment of neonatal hyperinsulinemic hypoglycemia is a rare, but previously described association. Risk factors for development of diazoxide-associated pulmonary hypertension include lower gestational age and congenital he...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Rachel T., Tillman, Kathryn A., Kindel, Steven J., Handler, Stephanie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869162/
https://www.ncbi.nlm.nih.gov/pubmed/33614015
http://dx.doi.org/10.1177/2045894020987117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869162/
https://www.ncbi.nlm.nih.gov/pubmed/33614015
http://dx.doi.org/10.1177/2045894020987117

Ejemplares similares